Our data show that miR-106a could promote adipocyte differentiation by targeting BAMBI. These findings will benefit both the control of meat quality in the animal husbandry industry and provide a new potential target for the human treatment of obesity and II type diabetes. Here, BAMBI is linked to type 2 diabetes mellitus.